|
|
||||||||
The Journal of Immunology, Vol 155, Issue 8 3938-3945, Copyright © 1995 by American Association of Immunologists
ARTICLES |
HX Liao, DM Lee, MC Levesque and BF Haynes
Department of Medicine, Duke Arthritis Center, Duke University Medical Center, Durham, NC 27710, USA.
CD44 molecules are cell surface receptors for hyaluronan (HA). To define regions of the extracellular domain of CD44 that are important for HA binding, we have studied the ability of HA-blocking CD44 mAbs to bind to CD44 from a variety of sources. Five CD44 mAbs (5F12, BRIC235, 3F12, BU-75, and HP2/9) of 21 studied were identified that at least partially blocked FITC-labeled HA (HA-FITC) binding to the standard form of CD44 (CD44S) in CD44-transfected Jurkat cells. Analysis of reactivity of HA-blocking CD44 mAbs defined three distinct epitopes. Lack of reactivity of mAb 5F12 with a CD44 fusion protein (CD44-Rg) containing an N-terminal truncation of 20 amino acids (aa), as well as reactivity of mAb 5F12 with an N-terminal CD44 synthetic peptide (CD44- 9A), demonstrated that the N-terminal proximal region of CD44 (aa 1 to 20) was involved in mAb 5F12 binding. A mutant cell line, CEM-NKR, derived from the T-ALL cell line, CEM, did not bind mAb 5F12 nor bind HA, whereas wild-type CEM did bind mAb 5F12 and HA. Sequence analysis of wild-type CEM and CEM-NKR CD44 cDNA demonstrated a G to A point mutation at position 575 in the CD44 cDNA of CEM-NKR, resulting in an arginine to histidine mutation at aa position 154. Taken together, our studies demonstrated that there are three epitopes to which HA-blocking mAbs bind in the extracellular domain of CD44, and that the CD44 N- terminal proximal and central regions are two regions in the extracellular domain of CD44 that may interact and either mediate or regulate HA binding to cell surface CD44.
This article has been cited by other articles:
![]() |
D. Vigetti, M. Viola, E. Karousou, M. Rizzi, P. Moretto, A. Genasetti, M. Clerici, V. C. Hascall, G. De Luca, and A. Passi Hyaluronan-CD44-ERK1/2 Regulate Human Aortic Smooth Muscle Cell Motility during Aging J. Biol. Chem., February 15, 2008; 283(7): 4448 - 4458. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, E. Gilad, and K. Peyrollier Heregulin-mediated ErbB2-ERK Signaling Activates Hyaluronan Synthases Leading to CD44-dependent Ovarian Tumor Cell Growth and Migration J. Biol. Chem., July 6, 2007; 282(27): 19426 - 19441. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, E. Gilad, K. Rothman, and K. Peyrollier Hyaluronan-CD44 Interaction with IQGAP1 Promotes Cdc42 and ERK Signaling, Leading to Actin Binding, Elk-1/Estrogen Receptor Transcriptional Activation, and Ovarian Cancer Progression J. Biol. Chem., March 25, 2005; 280(12): 11961 - 11972. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, P. A. Singleton, F. Diedrich, R. Stern, and E. Gilad CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion J. Biol. Chem., June 25, 2004; 279(26): 26991 - 27007. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, P. A. Singleton, H. Zhu, and F. Diedrich Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression J. Biol. Chem., August 8, 2003; 278(32): 29420 - 29434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Levesque and B. F. Haynes Activated T Lymphocytes Regulate Hyaluronan Binding to Monocyte CD44 Via Production of IL-2 and IFN-{{gamma}} J. Immunol., January 1, 2001; 166(1): 188 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, H. Zhu, L. Shao, and Y. W. Chen CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration J. Biol. Chem., January 21, 2000; 275(3): 1829 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tammi, D. MacCallum, V. C. Hascall, J.-P. Pienimaki, M. Hyttinen, and M. Tammi Hyaluronan Bound to CD44 on Keratinocytes Is Displaced by Hyaluronan Decasaccharides and Not Hexasaccharides J. Biol. Chem., October 30, 1998; 273(44): 28878 - 28888. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Haegel-Kronenberger, H. de la Salle, A. Bohbot, F. Oberling, J.-P. Cazenave, and D. Hanau Adhesive and/or Signaling Functions of CD44 Isoforms in Human Dendritic Cells J. Immunol., October 15, 1998; 161(8): 3902 - 3911. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, H. Zhu, A. Chu, N. Iida, L. Zhang, and M.-C. Hung Interaction between the Adhesion Receptor, CD44, and the Oncogene Product, p185HER2, Promotes Human Ovarian Tumor Cell Activation J. Biol. Chem., October 31, 1997; 272(44): 27913 - 27918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Telen, M. Udani, M. K. Washington, M. C. Levesque, E. Lloyd, and N. Rao A Blood Group-related Polymorphism of CD44 Abolishes a Hyaluronan-binding Consensus Sequence without Preventing Hyaluronan Binding J. Biol. Chem., March 22, 1996; 271(12): 7147 - 7153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lesley, V. C. Hascall, M. Tammi, and R. Hyman Hyaluronan Binding by Cell Surface CD44 J. Biol. Chem., August 25, 2000; 275(35): 26967 - 26975. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawashima, M. Hirose, J. Hirose, D. Nagakubo, A. H. K. Plaas, and M. Miyasaka Binding of a Large Chondroitin Sulfate/Dermatan Sulfate Proteoglycan, Versican, to L-selectin, P-selectin, and CD44 J. Biol. Chem., November 3, 2000; 275(45): 35448 - 35456. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. W. Bourguignon, H. Zhu, B. Zhou, F. Diedrich, P. A. Singleton, and M.-C. Hung Hyaluronan Promotes CD44v3-Vav2 Interaction with Grb2-p185HER2 and Induces Rac1 and Ras Signaling during Ovarian Tumor Cell Migration and Growth J. Biol. Chem., December 21, 2001; 276(52): 48679 - 48692. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cichy and E. Pure Oncostatin M and Transforming Growth Factor-beta 1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells J. Biol. Chem., June 9, 2000; 275(24): 18061 - 18069. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |